0001093557-15-000209.txt : 20150622 0001093557-15-000209.hdr.sgml : 20150622 20150622182009 ACCESSION NUMBER: 0001093557-15-000209 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150618 FILED AS OF DATE: 20150622 DATE AS OF CHANGE: 20150622 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROPER JESS CENTRAL INDEX KEY: 0001408993 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 15945680 MAIL ADDRESS: STREET 1: 5555 OBERLIN DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2015-06-18 0 0001093557 DEXCOM INC DXCM 0001408993 ROPER JESS 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 0 1 0 0 SVP, CFO Common Stock 2015-06-18 4 M 0 5500.0 9.8 A 113983 D Common Stock 2015-06-18 4 S 0 5500.0 77.2403 D 108483 D Common Stock 2015-06-18 4 M 0 500.0 7.63 A 108983 D Common Stock 2015-06-18 4 S 0 500.0 75.874 D 108483 D Common Stock 2015-06-18 4 S 0 1000.0 76.929 D 107483 D Incentive Stock Option (right to buy) 7.63 2015-06-18 4 M 0 500.0 75.874 D 2009-05-19 2018-05-19 Common Stock 500 0 D Non-Qualified Stock Option (right to buy) 9.8 2015-06-18 4 M 0 5500.0 77.2403 D 2011-03-12 2020-03-12 Common Stock 5500 29990 D On November 17, 2014, Mr. Roper adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Roper. The shares set forth above were sold pursuant to the 10b5-1 Plan. This transaction was executed in multiple trades at prices ranging from $76.28 to $77.61. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Included in this number are 70,000 unvested restricted stock units, 40,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 20,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017 and 10,000 of which were granted on March 11, 2013 and shall vest through March 11, 2016. This transaction was executed in multiple trades at prices ranging from $75.48 to $76.28. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. This transaction was executed in multiple trades at prices ranging from $75.48 to $77.67. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. By: John Lister For: Jess Roper 2015-06-22